Biochemical and behavioral effects of long-term citalopram administration and discontinuation in rats: Role of serotonin synthesis

Neurochemistry International

Volumn 57, Issue 8, 2010, Pages 948-957

  Bosker, Fokko J ^a   Tanke, Marit A C ^a   Jongsma, Minke E ^a,b   Cremers, Thomas I F H ^b   Jagtman, Evelien ^a   Pietersen, Charmaine Y ^a   Van Der Hart, Marieke G C ^a,b   Gladkevich, Anatoliy V ^a   Kema, Ido P ^a   Westerink, Ben H C ^b   Korf, Jakob ^a   Den Boer, Johan A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Discontinuation; Efficacy; Reactivity; Serotonin; SSRI; Synthesis; Turnover

Indexed keywords

BIOCHEMICAL MARKER; CITALOPRAM; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BEHAVIOR CHANGE; BRAIN TISSUE; CONTROLLED STUDY; DRUG WITHDRAWAL; LONG TERM EXPOSURE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; RAT; STARTLE REFLEX;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; CITALOPRAM; DEPRESSIVE DISORDER; MALE; RATS; RATS, WISTAR; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

RATTUS;

EID: 78649635889     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2010.10.001     Document Type: Article

References (84)

1. A. Adell, E. Castro, P. Celeda, A. Bortolozzi, A. Pazos, and F. Artigas Strategies for producing faster acting antidepressants Drug Discov. Today 10 2005 578 585
2. A. Adell, C. García-Marquez, A. Armario, and E. Gelpí Chronic administration of clomipramine prevents the increase in serotonin and noradrenaline induced by chronic stress Psychopharmacology (Berl.) 99 1989 22 26
3. I.M. Anderson SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability Depress. Anxiety 7 1 1998 11 17
4. F. Artigas 5-HT and antidepressants: new views from microdialysis studies Trends Pharmacol. Sci. 14 1993 262
5. D.A. Barton, M.D. Esler, T. Dawood, E.A. Lambert, D. Haikerwal, C. Brenchley, F. Socratous, J. Hastings, L. Guo, G. Wiesner, D.M. Kaye, R. Bayles, M.P. Schlaich, and G.W. Lambert Elevated brain serotonin turnover in patients with depression: effect of genotype and therapy Arch. Gen. Psychiatry 65 2008 38 46
6. P. Baumann Clinical pharmacokinetics of citalopram and other selective serotonergic reuptake inhibitors (SSRI) Int. Clin. Psychopharmacol. 6 5 1992 13 20
7. N. Bel, and F. Artigas Reduction of serotonergic function in rat brain by tryptophan depletion: effects in control and fluvoxamine-treated rats J. Neurochem. 67 1996 669 676
8. P. Blier, and P. Tremblay Physiologic mechanisms underlying the antidepressant discontinuation syndrome J. Clin. Psychiatry 67 4 2006 8 13
9. P. Blier, C. de Montigny, and Y. Chaput Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression J. Clin. Psychopharmacol. 7 1987 24S 35S
10. F.J. Bosker, K.E. van Esseveldt, A.A. Klompmakers, and H.G. Westenberg Chronic treatment with fluvoxamine by osmotic minipumps fails to induce persistent functional changes in central 5-HT1A and 5-HT1B receptors, as measured by in vivo microdialysis in dorsal hippocampus of conscious rats Psychopharmacology (Berl.) 117 1995 358 363
11. F.J. Bosker, T.Y. de Winter, A.A. Klompmakers, and H.G. Westenberg Flesinoxan dose-dependently reduces extracellular 5-hydroxytryptamine (5-HT) in rat median raphe and dorsal hippocampus through activation of 5-HT1A receptors J. Neurochem. 66 1996 2546 2555
12. J.M. Bjork, O. Gaytan, N. Patt, A.C. Swann, and N. Dafny Behavioral tolerance to and withdrawal from multiple fluoxetine administration Int. J. Neurosci. 93 1998 163 179
13. S. Caccia, M. Anelli, A.M. Codegoni, C. Fracasso, and S. Garattini The effects of single and repeated anorectic doses of 5-hydroxytryptamine uptake inhibitors on indole levels in rat brain Br. J. Pharmacol. 110 1993 355 359
14. D. Calderón-Guzmán, J.L. Hernández-Islas, I. Espitia-Vázquez, G. Barragán-Mejía, E. Hernández- García, D. Santamaría-del Angel, and H. Juárez- Olguín Pyridoxine, regardless of serotonin levels, increases production of 5-hydroxytryptophan in rat brain Arch. Med. Res. 35 2004 271 274
15. I. Ceglia, S. Acconcia, C. Fracasso, M. Colovic, S. Caccia, and R.W. Invernizzi Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors Br. J. Pharmacol. 142 2004 469 478
16. Y. Chaput, C. de Montigny, and P. Blier Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat Neuropsychopharmacology 5 1991 219 229
17. G.L. Chen, E.J. Vallender, and G.M. Miller Functional characterization of the human TPH2 5' regulatory region: untranslated region and polymorphisms modulate gene expression in vitro Hum. Genet. 122 2008 645 657
18. T.I. Cremers, P. de Boer, Y. Liao, F.J. Bosker, J.A. den Boer, B.H. Westerink, and H.V. Wikström Augmentation with a 5-HT(1A), but not a 5-HT(1B) receptor antagonist critically depends on the dose of citalopram Eur. J. Pharmacol. 397 2000 63 74
19. T.I. Cremers, E.N. Spoelstra, P. de Boer, F.J. Bosker, A. Mork, J.A. den Boer, B.H. Westerink, and H.V. Wikström Desensitisation of 5-HT autoreceptors upon pharmacokinetically monitored chronic treatment with citalopram Eur. J. Pharmacol. 397 2000 351 357
20. T.I. Cremers, M. Giorgetti, F.J. Bosker, S. Hogg, J. Arnt, A. Mørk, G. Honig, K.P. Bøgesø, B.H. Westerink, H. den Boer, H.V. Wikstrom, and L.H. Tecott Inactivation of 5-HT(2C) receptors potentiates consequences of serotonin reuptake blockade Neuropsychopharmacology 29 2004 1782 1789
21. M. Davis, and M.H. Sheard Habituation and sensitization of the rat startle response: effects of raphe lesions Physiol. Behav. 12 1974 425 431
22. M. Davis, D.I. Strachan, and E. Kass Excitatory and inhibitory effects of serotonin on sensorimotor reactivity measured with acoustic startle Science 209 1980 521 523
23. P.L. Delgado, D.S. Charney, L.H. Price, G.K. Aghajanian, H. Landis, and G.R. Heninger Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan Arch. Gen. Psychiatry 47 1990 411 418
24. K. Demyttenaere, and P. Haddad Compliance with antidepressant therapy and antidepressant discontinuation symptoms Acta Psychiatr. Scand. Suppl. 403 2000 50 56
25. K. Demyttenaere, P. Mesters, B. Boulanger, W. Dewe, M.H. Delsemme, J. Gregoire, and E. Van Ganse Adherence to treatment regimen in depressed patients treated with amitriptyline or fluoxetine J. Affect. Disord. 65 2001 243 252
26. M.T. Eaddy, B.G. Druss, M.W. Sarnes, T.S. Regan, and L.E. Frankum Relationship of total health care charges to selective serotonin reuptake inhibitor utilization patterns including the length of antidepressant therapy - results from a managed care administrative claims database J. Manag. Care Pharm. 11 2005 145 150
27. S. Esteban, J. Llado, A. Sastre-Coll, and J.A. Garsia-Sevilla Activation and desensitization by cyclic antidepressant drugs of alpha(2)-autoreceptors, alpha(2)-heteroreceptors and 5-HT1A-autoreceptors regulating monoamine synthesis in the rat brain in vivo Naunyn-Schmiedebergs Arch. Pharmacol. 360 1999 135 143
28. J.C. Fournier, R.J. DeRubeis, S.D. Hollon, S. Dimidjian, J.D. Amsterdam, R.C. Shelton, and J. Fawcett Antidepressant drug effects and depression severity: a patient-level meta-analysis JAMA 6 2010 47 53
29. O.K. Fredricson Kinetics of citalopram in test animals; drug exposure in safety studies Prog. Neuropsychopharmacol. Biol. Psychiatry 6 1982 297 309
30. R.A. Friedman, and A.C. Leon Expanding the black box - depression, antidepressants, and the risk of suicide N. Engl. J. Med. 356 2007 2343 2346
31. R.W. Fuller Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis Life Sci. 55 1994 163 167
32. M.A. Geyer, and G.S. Tapson Habituation of tactile startle is altered by drugs acting on serotonin-2 receptors Neuropsychopharmacology 1 1988 135 147
33. C. Grillon, J. Levenson, and D.S. Pine A single dose of the selective serotonin reuptake inhibitor citalopram exacerbates anxiety in humans: a fear-potentiated startle study Neuropsychopharmacology 32 2007 225 231
34. P.M. Haddad Antidepressant discontinuation syndromes Drug Saf. 24 2001 183 197
35. C.J. Harmer, N.C. Shelley, P.J. Cowen, and G.M. Goodwin Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition Am. J. Psychiatry 161 2004 1256 1263
36. S. Hasegawa, A. Watanabe, K.Q. Nguyen, G. Debonnel, and M. Diksic Chronic administration of citalopram in olfactory bulbectomy rats restores brain 5-HT synthesis rates: an autoradiographic study Psychopharmacology (Berl.) 179 2005 781 790
37. D. Healy, and G. Aldred Antidepressant drug use & the risk of suicide Int. Rev. Psychiatry 17 2005 163 172
38. D. Healy Did regulators fail over selective serotonin reuptake inhibitors? B.M.J. 333 2006 92 95
39. J.R. Homberg, J.D. Olivier, and B.M. Smits Characterization of the serotonin transporter knockout rat: a selective change in the functioning of the serotonergic system Neuroscience 146 2007 1662 1676
40. G. Honig, M. Jongsma, M.C.G. van der Hart, and L.H. Tecott Chronic citalopram administration causes a sustained suppression of serotonin synthesis in the mouse forebrain PloS ONE 4 8 2009 e66797 10.1371/journal.pone.0006797
41. J. Hyttel Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs) Int. Clin. Psychopharmacol. 9 1 1994 19 26
42. R.W. Invernizzi Role of TPH-2 in brain function: news from behavioral and pharmacologic studies J. Neurosci. Res. 85 2007 3030 3035
43. K.S. Jensen, B. Oranje, M. Wienberg, and B.Y. Glenthoj The effects of increased central serotonergic activity on prepulse inhibition and habituation of the human startle response Neuropsychopharmacology 32 2007 2117 2124 (Pubitemid 47417698)
44. M.E. Jongsma, F.J. Bosker, T.I. Cremers, B.H. Westerink, and J.A. den Boer The effect of chronic selective serotonin reuptake inhibitor treatment on serotonin 1B receptor sensitivity and HPA axis activity Prog. Neuropsychopharmacol. Biol. Psychiatry 29 2005 738 744
45. M.E. Jongsma, M.C.G. van der Hart, J.I. Udo de Haes, T.I. Cremers, B.H.C. Westerink, J.A. den Boer, and F.J. Bosker Augmentation strategies to improve treatment of major depression CNSA-MC 6 2006 135 152
46. K. Kanemaru, K. Nishi, S. Hasegawa, and M. Diksic Chronic citalopram treatment elevates serotonin synthesis in flinders sensitive and flinders resistant lines of rats, with no significant effect on Sprague-Dawley rats Neurochem. Int. 54 2009 363 371
47. I.P. Kema, W.G. Meijer, G. Meiborg, B. Ooms, P.H. Willemse, and E.G. de Vries Profiling of tryptophan-related plasma indoles in patients with carcinoid tumors by automated, on-line, solid-phase extraction and HPLC with fluorescence detection Clin. Chem. 47 2001 1811 1820
48. Kirsch, I., Moore, T.J., Scoboria, A., Nicholls S.S., 2002. Prevention & Treatment I. http://www.journals.apa.org/prevention.
49. I. Kirsch, B.J. Deacon, T.B. Huedo-Medina, A. Scoboria, T.J. Moore, and B.T. Johnson Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration PLoS Med. 5 2008 e45 10.1371/journal.pmed.0050045
50. P. Kragh-Sørensen, K.F. Overø, O.L. Petersen, K. Jensen, and W. Parnas The kinetics of citalopram: single and multiple dose studies in man Acta Pharmacol. Toxicol. (Copenh.) 48 1981 53 60
51. B.E. Leonard Pharmacological effects of serotonin reuptake inhibitors J. Clin. Psychiatry 49 1988 12 17
52. M.E. Liechti, M.A. Geyer, D. Hell, and F.X. Vollenweider Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin Neuropsychopharmacology 24 2001 240 252
53. D.L. Martinez, and M.A. Geyer Characterization of the disruptions of prepulse inhibition and habituation of startle induced by alpha-ethyltryptamine Neuropsychopharmacology 16 1997 246 255
54. C. Moret, and M. Briley Serotonin autoreceptor subsensitivity and antidepressant activity Eur. J. Pharmacol. 16 1990 351 356
55. C. Moret, and M. Briley Effect of antidepressant drugs on monoamine synthesis in brain in vivo Neuropharmacology 31 1992 679 684
56. C.J. Morgan, and A.A. Badawy Effects of storage on binding and stability of tryptophan in human serum Ann. Clin. Biochem. 31 1994 190 192
57. J. Neumaier, D. Root, and M. Hamblin Chronic fluoxetine reduces serotonin transporter mRNA and 5-HT1B mRNA in a sequential manner in the rat dorsal raphe nucleus Neuropsychopharmacology 15 1996 515 522
58. J.J. O'Connor, and Z.L. Kruk Effects of 21 days treatment with fluoxetine on stimulated endogenous 5-hydroxytryptamine overflow in the rat dorsal raphe and suprachiasmatic nucleus studied using fast cyclic voltammetry in vitro Brain Res. 21 1994 328 335
59. J.C. O'Connor, C. André, Y. Wang, M.A. Lawson, S.S. Szegedi, J. Lestage, N. Castanon, K.W. Kelley, and R. Dantzer Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin J. Neurosci. 29 2009 4200 4209
60. E. Oyehaug, E.T. Ostensen, and B. Salvesen Determination of the antidepressant agent citalopram and metabolites in plasma by liquid chromatography with fluorescence detection J. Chromatogr. 227 1982 129 135
61. B. Pouzet, M.P. Andersen, and S. Hogg Effects of acute treatment with antidepressant drugs on sensorimotor gating deficits in rats Psychopharmacology (Berl.) 178 2005 9 16
62. S.B. Ross, H. Hall, A.L. Renyi, and D. Westerlund Effects of zimelidine on serotoninergic and noradrenergic neurons after repeated administration in the rat Psychopharmacology (Berl.) 72 1981 219 225
63. S. Russo, I.P. Kema, E.B. Haagsma, J.C. Boon, P.H. Willemse, J.A. den Boer, E.G. de Vries, and J. Korf Irritability rather than depression during interferon treatment is linked to increased tryptophan catabolism Psychosom. Med. 67 2005 773 777
64. S. Russo, I.P. Kema, M.R. Fokkema, J.C. Boon, P.H. Willemse, E.G. de Vries, J.A. den Boer, and J. Korf Tryptophan as a link between psychopathology and somatic states Psychosom. Med. 65 2003 665 671
65. S. Russo, I.P. Kema, F.J. Bosker, J. Haavik, and J. Korf Tryptophan as an evolutionarily conserved signal to brain serotonin: Molecular evidence and psychiatric implications World J. Biol. Psychiatry 10 2009 258 268
66. S. Russo, J.C. Boon, I.P. Kema, P.H. Willemse, J.A. Den Boer, J. Korf, and E.G. de Vries Patients with carcinoid syndrome exhibit symptoms of aggressive impulse dysregulation Psychosom. Med. 66 2004 422 425
67. A.F. Schatzberg, P. Blier, P.L. Delgado, M. Fava, P.M. Haddad, and R.C. Shelton Antidepressant discontinuation syndrome: consensus panel recommendations for clinical management and additional research J. Clin. Psychiatry 67 4 2006 27 30
68. S.C. Sharp, and J.A. Hellings Efficacy and safety of selective serotonin reuptake inhibitors in the treatment of depression in children and adolescents: practitioner review Clin. Drug Investig. 26 2006 247 255
69. L. Sher Prevention of the serotonin reuptake inhibitor discontinuation syndrome Med. Hypotheses 59 2002 92 94
70. G.E. Simon, and J. Savarino Suicide attempts among patients starting depression treatment with medications or psychotherapy Am. J. Psychiatry 164 2007 1029 1034
71. A.J. Sleight, R.J. Smith, C.A. Marsden, and M.G. Palfreyman The effects of chronic treatment with amitriptyline and MDL 72394 on the control of 5-HT release in vivo Neuropharmacology 28 1989 477 480
72. C. Stenfors, and S. Ross Evidence for involvement of hydroxytryptamine (1B)autoreceptors in the enhancement of serotonin turnover in the mouse brain following repeated treatment with fluoxetine Life Sci. 71 2002 2867 2880
73. J.S. Sprouse, and G.K. Aghajanian Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists Synapse 1 1987 3 9
74. M.A. Tanke, E. Alserda, B. Doornbos, P.J. van der Most, K. Goeman, F. Postema, and J. Korf Low tryptophan diet increases stress-sensitivity, but does not affect habituation in rats Neurochem. Int. 52 2008 272 281
75. J.H. Trouvin, A.M. Gardier, E. Chanut, N. Pages, and C. Jacquot Time course of brain serotonin metabolism after cessation of long-term fluoxetine treatment in the rat Life Sci. 52 1993 PL187 192
76. R.J. Valuck, H.D. Orton, and A.M. Libby Antidepressant discontinuation and risk of suicide attempt: a retrospective, nested case-control study J. Clin. Psychiatry 70 2009 1069 1077
77. A.R. Van Gool, D. Fekkes, W.H. Kruit, P.G. Mulder, T.L. Ten Hagen, M. Bannink, M. Maes, and A.M. Eggermont Serum amino acids, biopterin and neopterin during long-term immunotherapy with interferon-alpha in high-risk melanoma patients Psychiatry Res. 119 2003 125 132
78. A.R. Van Gool, H.H. van Ojik, W.H. Kruit, M. Bannink, P.G. Mulder, A.M. Eggermont, r.G. Stote, and D. Fekkes Pegylated interferon-alpha2b treatment in melanoma patients: influence on amino acids, 5-hydroxyindolacetic acid and pteridine plasma concentrations Anticancer Drugs 15 2004 587 591
79. H.M. van der Stelt, L.M. Broersen, B. Olivier, and H.G. Westenberg Effects of dietary tryptophan variations on extracellular serotonin in the dorsal hippocampus of rats Psychopharmacology (Berl.) 172 2004 137 144
80. M. Vergnes, and E. Kempf Tryptophan deprivation: effects on mouse-killing and reactivity in the rat Pharmacol. Biochem. Behav. 14 1 1981 19 23
81. A.H. Veenema, T.I. Cremers, M.E. Jongsma, P.J. Steenbergen, S.F. De Boer, and J.M. Koolhaas Differences in the effects of 5-HT(1A) receptor agonists on forced swimming behavior and brain 5-HT metabolism between low and high aggressive mice Psychopharmacology (Berl.) 178 2005 151 160
82. J.K. Walters, M. Davis, and M.H. Sheard Tryptophan-free diet: effects on the acoustic startle reflex in rats Psychopharmacology (Berl.) 62 1979 103 109
83. Y. Wang, M.A. Lawson, R. Dantzer, and K.W. Kelley LPS-induced indoleamine 2,3-dioxygenase is regulated in an interferon-gamma-independent manner by a JNK signaling pathway in primary murine microglia Brain Behav. Immun. 24 2010 201 209
84. C.H. Warner, W. Bobo, C. Warner, S. Reid, and J. Rachal Antidepressant discontinuation syndrome Am. Fam. Phys. 74 2006 449 456